About Us

Stacey Tucker – Finance Director

Stacey is Oxular’s Finance Director since 2018 and brings significant knowledge and experience in all aspects of finance, administration, and human resources involved with managing a biotech start-up.  Stacey provides cross-functional leadership and operational oversight, manages the entire finance function, including support of business financings, and investor and board relations. Stacey also coordinates information technology …

Stacey Tucker – Finance Director Read More »

Chris Verbicky – VP of GMP Drug manufacturing

Chris is Oxular’s Vice President of GMP Drug Manufacturing, with more than 25 years of industry experience, Chris’s experience spans chemistry, manufacturing, and manufacturing controls, pilot-to-full scale production project management in both APIs and finished product, alliance management, injectable product development, formulation development, process development and scale-up, and licensing and partnering. He has also authored or contributed to over 70 patents, publications, and presentations concerning project management, business, and pharmaceutical development. Chris received a BS in Chemistry and an MBA from the University of Albany, USA, and holds a PhD in Synthetic Organic Chemistry from the University of New Hampshire, USA.

Pamela Lapham – SR Director of Regulatory

Pamela is Oxular’s Senior Director of Regulatory Affairs, with over 30 years of experience working in all aspects of regulatory strategy and submissions. Previously, Pamela managed and coordinated regulatory efforts at Genocea, ProMedDx and Ximedica. She has significant experience in regulatory development, strategy, and filings and brings technical experience in clinical trials design, chemistry, manufacturing, …

Pamela Lapham – SR Director of Regulatory Read More »

Ian Anderson – VP of Medical Devices

Ian is Oxular’s Vice President of Medical Device Development and Manufacturing. He has significant experience in all technical aspects of medical device development and high-volume medical product industrialization. Ian journeyed from aeronautical and broadcast engineering into medical technologies, where he has been involved in the design, development, and launch of products as varied as surgical …

Ian Anderson – VP of Medical Devices Read More »

Dr Jatinder Kapur – VP of Quality

Jatinder is Oxular’s Vice President of Quality. He has more than 25 years of experience in the quality assurance function, amassing extensive knowledge in the development and auditing processes of pharmaceuticals, including sterile injectables, oral dosage forms, and liquid suspension preparations, as well as medical devices. Jatinder has worked with several quality pharmaceutical companies, such as Novartis, Shire, and BTG, and has significant experience working with combination medical device and pharmaceutical products. He has overseen product technology transfers, designed and commissioned a sterile API plant, and established numerous quality management systems. He holds a PhD in Synthetic Organic Chemistry from Punjab University, India.

Tassos Konstantinou Director

Tassos is an investment manager at IP Group and specializes in early stage investing in the life science sector. Before joining IP Group, Tassos was a business development executive at CRUK Commercial Partnerships (formerly CRT) where he led the intellectual property sourcing, licensing, and spin-out creation of CRUK-funded technologies. He has experience in technology transfer …

Tassos Konstantinou Director Read More »

Dr. Dmitrij Hristodorov Director

Dmitrij Hristodorov, PhD, is Partner at Forbion where, as a core member of the investment team, he contributes to investments across various stages, treatment modalities and diseases. Previously, he was Senior Director of Global Business Development & Licensing at Bayer Pharma, where he was responsible for ophthalmology, cardiology, nephrology, and pulmonology. Dmitrij currently serves as …

Dr. Dmitrij Hristodorov Director Read More »

Christina Takke Director

Christina is co-founder and Managing Director of V-Bio Ventures. With more than 20 years of investment experience in European venture capital, Christina was previously a partner with Forbion Capital Partners (formerly ABN AMRO Capital) where she led and managed a series of successful biotech investments since 2001. Christina currently serves on the boards of Confo …

Christina Takke Director Read More »

Geert-Jan Mulder, MD

Geert-Jan is Managing Partner at Forbion and has a leading role in the firm’s investment team and portfolio. He is an experienced life sciences investor who is led Forbion’s successful investments and served on the Boards of several Forbion portfolio companies, sometimes also in an executive capacity. In addition to his portfolio management activities, he …

Geert-Jan Mulder, MD Read More »

Professor Marc de Smet Senior Medical Advisor

Marc is Oxular’s Senior Medical Advisor and a practicing vitreoretinal surgeon, with more than 30 years of experience in ophthalmic drug and medical device development. Previously, he was the National Eye Institute’s representative responsible for defining the clinical trial of Foscarnet, the first approved drug to treat CMV retinitis in AIDS patients. He initiated the …

Professor Marc de Smet Senior Medical Advisor Read More »

Scroll to Top